Thailand's FDA approves China's Sinopharm vaccine for emergency use


A medical worker holds a package for a Sinopharm vaccine at a vaccination facility in Beijing on Jan. 15, 2021. Two vaccines made by China’s Sinopharm appear to be safe and effective against Covid-19, according to a study published in a medical journal. Scientists have been waiting for more details about the two vaccines, even though they already are being used in many countries and one recently won the backing of the World Health Organisation. - AP

BANGKOK, May 28 (Reuters): Thailand's food and drug regulator on Friday approved for emergency use the coroanvirus vaccine developed by China's Sinopharm, a senior official said.

"The FDA has approved the Sinopharm vaccine," senior health official Paisan Dankhum told a news conference, making it the fifth Covid-19 vaccine Thailand has approved.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , Covid-19 , FDA , Approve , Sinopharm , Vaccine , Emergency , Usage

Next In Aseanplus News

Senior BJP party leader Sanjay Tandon hails youth as driving force behind India’s journey towards Viksit Bharat
As China ends its fishing ban in East China Sea, Japan to monitor situation amid deteriorating Tokyo-Beijing relations
Korea's southeastern region reports over 2,500 cases of storm damage
Thailand to expand Suvarnabhumi Airport auto gates to more nationalities
16 hikers hit by hypothermia, injuries during Indonesia independence day climb
China lowers flags, tightens security for former premier Zhu Rongji's funeral
Two men arrested in Singapore for allegedly breaking into Balestier temple, stealing cash from donation boxes
Ringgit strengthens vs major currencies, little changed against greenback
FBM KLCI holds steady as geopolitical risk mounts
Alam Maritim CEO remanded by the MACC

Others Also Read